Genovis AB, a leading provider of innovative enzyme technologies, today announces a strategic partnership with Single Cell Discoveries to broaden the application of the SEQURNA® Thermostable RNase Inh ...
Background High serum levels of interleukin 6 (IL-6) predict poor prognosis in intrahepatic cholangiocarcinoma (iCCA), a malignancy that often develops in a chronically inflamed milieu . Here, tumour ...
HAMBURG, DE / ACCESS Newswire / March 19, 2026 / Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced that its partner Bristol Myers Squibb (BMS) has initiated a Phase 1 clinical study ...
As climate pressure mounts, new platforms tackle delivery, regulation, trait stacking, and data bottlenecks limiting agricultural genome editing.
Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.
As non-animal models enter mainstream drug development, regulatory readiness lags behind scientific progress. Experts emphasize standardized terminology, shared datasets, and negative data to support ...
Dosing of first patient initiates Phase 1 clinical evaluation of BMS-986506 for the treatment of advanced clear cell renal cell carcinoma, the most common form of kidney cancerTransformative moment in ...
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide, driven by complex and heterogeneous molecular mechanisms ...
The field of immunology has long recognized immune system dysregulation as a cornerstone of pathogenesis across a range of human diseases, including ...
Proteoforms, the diverse molecular variants of proteins, are key to understanding cellular functions, disease mechanisms, and biomarker discovery in proteomics.
Increasing the efficiency of LNPs as therapeutic vehicles offers promise for better mRNA-based and gene editing treatment success.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results